DENTSPLY SIRONA Inc. (XRAY)

NASDAQ: XRAY · Real-Time Price · USD
11.78
-0.18 (-1.51%)
At close: Apr 28, 2026, 4:00 PM EDT
11.76
-0.02 (-0.21%)
After-hours: Apr 28, 2026, 4:16 PM EDT
-1.51%
Market Cap 2.35B
Revenue (ttm) 3.68B
Net Income (ttm) -598.00M
Shares Out 199.55M
EPS (ttm) -3.00
PE Ratio n/a
Forward PE 8.37
Dividend $0.64 (5.43%)
Ex-Dividend Date Dec 26, 2025
Volume 2,948,267
Open 11.96
Previous Close 11.96
Day's Range 11.64 - 11.98
52-Week Range 9.85 - 17.18
Beta 1.00
Analysts Hold
Price Target 14.58 (+23.77%)
Earnings Date May 5, 2026

About XRAY

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as w... [Read more]

Sector Healthcare
IPO Date Aug 12, 1987
Employees 14,000
Stock Exchange NASDAQ
Ticker Symbol XRAY
Full Company Profile

Financial Performance

In 2025, DENTSPLY SIRONA's revenue was $3.68 billion, a decrease of -2.98% compared to the previous year's $3.79 billion. Losses were -$598.00 million, -34.29% less than in 2024.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for XRAY stock is "Hold." The 12-month stock price target is $14.58, which is an increase of 23.77% from the latest price.

Price Target
$14.58
(23.77% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5

CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and ...

6 days ago - GlobeNewsWire

DENTSPLY SIRONA Transcript: Leerink Global Healthcare Conference 2026

Leadership is driving a turnaround with urgent execution, strategic R&D focus, and simplified dealer partnerships. Investments in clinical education, AI, and product modernization are expected to yield results in the second half, with EMEA and Asia Pacific as key growth regions.

7 weeks ago - Transcripts

First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics

Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI 1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United...

7 weeks ago - GlobeNewsWire

Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026

CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners G...

7 weeks ago - GlobeNewsWire

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Other symbols: PFEPRGO
2 months ago - Benzinga

DENTSPLY SIRONA Earnings Call Transcript: Q4 2025

Q4 and full-year 2025 results met expectations, with revenue growth in key segments and margin expansion despite tariff headwinds. The 2026 outlook includes lower sales, higher R&D investment, a dividend cut, and a focus on U.S. growth and operational transformation.

2 months ago - Transcripts

Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

News Summary Q4 2025 net sales of $961 million increased 6.2% , constant currency sales increased 2.5% Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodw...

2 months ago - GlobeNewsWire

HALPER SADEH LLC ENCOURAGES DENTSPLY SIRONA INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...

2 months ago - PRNewsWire

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term value creation New directors bring decades of fina...

2 months ago - GlobeNewsWire

Dentsply Sirona and Burkhart Dental Supply Announce Expanded Distribution Partnership to Include Dental Technology Equipment

As of April 1, Burkhart Dental Supply will represent Dentsply Sirona's full portfolio of dental technology solutions in addition to preventive and restorative solutions it already distributes. The exp...

2 months ago - GlobeNewsWire

Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26

CHARLOTTE, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and l...

2 months ago - GlobeNewsWire

Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties...

3 months ago - Business Wire

Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership

CHARLOTTE, N.C., Jan. 14, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologie...

3 months ago - GlobeNewsWire

DENTSPLY SIRONA Transcript: 44th Annual J.P. Morgan Healthcare Conference

A new CEO is driving a turnaround with a focus on innovation, digital transformation, and operational efficiency. Key initiatives include expanding the DS Core platform, increasing R&D investment, restructuring U.S. operations, and targeting sequential growth by late 2026.

3 months ago - Transcripts

Dentsply Sirona and Benco Dental Announce Expanded Partnership to Include Dental Technology Solutions

Benco Dental will offer Dentsply Sirona's full portfolio of dental technology solutions, in addition to the consumables portfolio. Expanding the decades-long relationship reflects a shared vision to a...

3 months ago - GlobeNewsWire

Dentsply Sirona Appoints Donald Zurbay to Board of Directors

CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Direc...

3 months ago - GlobeNewsWire

Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental product...

3 months ago - GlobeNewsWire

Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference

CHARLOTTE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 44th Annual J.P. Mo...

3 months ago - GlobeNewsWire

Dentsply Sirona Declares Quarterly Cash Dividend

CHARLOTTE, N.C., Dec. 15, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of ...

4 months ago - GlobeNewsWire

Dentsply Sirona Stock Sinks On Missed Expectations, Lowered 2025 Guidance; CEO Unveils Return-To-Growth Plan

Dentsply Sirona Inc. (NASDAQ:XRAY) stock is trading lower on Thursday after weaker-than-expected third-quarter earnings and lowered guidance.

6 months ago - Benzinga

DENTSPLY SIRONA Earnings Call Transcript: Q3 2025

Q3 sales declined 5% as reported, with U.S. sales down sharply but Europe growing modestly. The company revised 2025 guidance downward and is accelerating R&D and operational changes, with a new leadership team and a four-pillar turnaround plan focused on growth and efficiency.

6 months ago - Transcripts

Dentsply Sirona Reports Third Quarter 2025 Results

CHARLOTTE, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2025 and intr...

6 months ago - GlobeNewsWire

Dentsply Sirona to Host Third Quarter Conference Call on November 6th

CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and l...

7 months ago - GlobeNewsWire

Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization

CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice Preside...

7 months ago - GlobeNewsWire

Dentsply Sirona and Pearl Partner to Deliver Advanced AI-Assisted Radiologic Support via DS Core Integration

LOS ANGELES--(BUSINESS WIRE)-- #ArtificialIntelligence--Dentsply Sirona adds Pearl's Second Opinion dental AI capabilities to its cloud-based DS Core imaging software.

7 months ago - Business Wire